Who
Shalom Hirschman
Director
Company insider
Files Form 4 as: Director, Klotho Neurosciences; Director, Quantrx Biomedical.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 29 Dec 2006
- Last trade
- 4 Mar 2026
- Last filed
- 6 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Mar 2026filed 6 Mar 2026 | Klotho NeurosciencesBiotechnology | SEC FORM 4 Code A | —350,000 | filing |
| 4 Mar 2026filed 6 Mar 2026 | GRML Greenland MinesBiotechnology | SEC FORM 4 Code A | —350,000 | filing |
| 5 Aug 2025filed 8 Aug 2025 | GRML Greenland MinesBiotechnology | SEC FORM 4 Code A | —70,149 | filing |
| 25 May 2012filed 27 Sep 2012 | Quantrx Biomedical | SEC FORM 4 Code J | $9,000150,000 at $0.06 | filing |
| 31 Dec 2009filed 6 Jan 2010 | Quantrx Biomedicaloption or derivative | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 29 Dec 2006filed 20 Mar 2007 | Quantrx Biomedicaloption or derivative | SEC FORM 4 Code A | —6,250 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.